| 前收盘价格 | 88.88 |
| 收盘价格 | 89.78 |
| 成交量 | 596,516 |
| 平均成交量 (3个月) | 1,171,580 |
| 市值 | 22,473,510,912 |
| 预期市盈率 (P/E Forward) | 7.04 |
| 价格/销量 (P/S) | 6.56 |
| 股市价格/股市净资产 (P/B) | 1.02 |
| 52周波幅 | |
| 利润日期 | 5 May 2026 |
| 营业毛利率 | -27.89% |
| 营业利益率 (TTM) | -270.46% |
| 稀释每股收益 (EPS TTM) | -3.72 |
| 季度收入增长率 (YOY) | -2.60% |
| 季度盈利增长率 (YOY) | -43.30% |
| 总债务/股东权益 (D/E MRQ) | 1.55% |
| 流动比率 (MRQ) | 10.18 |
| 营业现金流 (OCF TTM) | -255.70 M |
| 杠杆自由现金流 (LFCF TTM) | -335.98 M |
| 资产报酬率 (ROA TTM) | -3.67% |
| 股东权益报酬率 (ROE TTM) | -3.94% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | BioNTech SE | 看涨 | 看跌 |
AIStockmoo 评分
2.3
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 2.25 |
|
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 62.69% |
| 机构持股比例 | 22.24% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Primecap Management Co/Ca/ | 31 Dec 2025 | 3,800,011 |
| Dodge & Cox | 31 Dec 2025 | 3,614,491 |
| Temasek Holdings (Private) Ltd | 31 Dec 2025 | 1,506,027 |
| Baillie Gifford & Co | 31 Dec 2025 | 1,244,867 |
| Gsk Plc | 31 Dec 2025 | 889,824 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 171.00 (Canaccord Genuity, 91.23%) | 购买 |
| 中 | 130.00 (45.38%) | |
| 低 | 94.00 (TD Cowen, 5.12%) | 保留 |
| 平均值 | 132.57 (48.26%) | |
| 总计 | 6 购买, 1 保留 | |
| 平均价格@调整类型 | 92.44 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BMO Capital | 11 Mar 2026 | 128.00 (43.14%) | 购买 | 90.84 |
| Canaccord Genuity | 11 Mar 2026 | 171.00 (91.23%) | 购买 | 90.84 |
| Citigroup | 11 Mar 2026 | 130.00 (45.38%) | 购买 | 90.84 |
| Morgan Stanley | 11 Mar 2026 | 125.00 (39.79%) | 购买 | 90.84 |
| TD Cowen | 11 Mar 2026 | 94.00 (5.12%) | 保留 | 90.84 |
| Jefferies | 10 Mar 2026 | 138.00 (54.33%) | 购买 | 83.89 |
| Goldman Sachs | 16 Jan 2026 | 142.00 (58.80%) | 购买 | 109.00 |
该时间范围内无数据。
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 02 Jun 2022 | - | 17 Jun 2022 | 2.111 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2022 | 2.11 | 1 | 1.41 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合